Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
This is the primary clinical rationale for IV administration when therapeutic-level replenishment is the goal
Employers who proactively engage with their PBMs and stay informed about market changes will be best positioned to optimize health outcomes and manage costs in this dynamic space.
Available from: Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, et al
J.ChoS.HongJ
This enhanced insulin response contributes to superior glycemic control, which is why tirzepatide performs exceptionally well in populations with type 2 diabetes
Arvanitakis K, Koufakis T, Popovic D, Maltese G, Mustafa O, Doumas M, et al
US$ 27.95
US$ 27.60
US$ 27.18
US$ 26.33
US$ 29.38
US$ 20.48
US$ 23.15
US$ 29.18
US$ 21.07
